Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-etomidate syringe order and myoclonus during painless gastrointestinal endoscopy
ChiCTR2600135788Phase 4Not yet recruiting
- Sponsor
- Nanjing Medical University Affiliated Wuxi Second Hospital
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of propofol and etomidate (2 arms), sponsored by Nanjing Medical University Affiliated Wuxi Second Hospital. Primary endpoint: Incidence of myoclonus. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
propofoletomidate
Beyond the preview
Go deeper on ChiCTR2600135788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600135788.